Schellekens AFA - Search Results

1

The role of the habenula in the transition from reward to misery in substance use and mood disorders.

Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens AFA, Loonen AJM. Batalla A, et al. Among authors: schellekens afa. Neurosci Biobehav Rev. 2017 Sep;80:276-285. doi: 10.1016/j.neubiorev.2017.03.019. Epub 2017 May 30. Neurosci Biobehav Rev. 2017. PMID: 28576510 Review.

2

Ibogaine and addiction in the animal model, a systematic review and meta-analysis.

Belgers M, Leenaars M, Homberg JR, Ritskes-Hoitinga M, Schellekens AF, Hooijmans CR. Belgers M, et al. Transl Psychiatry. 2016 May 31;6(5):e826. doi: 10.1038/tp.2016.71. Transl Psychiatry. 2016. PMID: 27244235 Free PMC article. Review.

3

Rethinking the risk-benefit ratio of efavirenz in HIV-infected children.

Van de Wijer L, Schellekens AFA, Burger DM, Homberg JR, de Mast Q, van der Ven AJAM. Van de Wijer L, et al. Among authors: schellekens afa. Lancet Infect Dis. 2016 May;16(5):e76-e81. doi: 10.1016/S1473-3099(16)00117-1. Epub 2016 Apr 18. Lancet Infect Dis. 2016. PMID: 27599655 Review.

4

Psilocybin for treating substance use disorders?

de Veen BT, Schellekens AF, Verheij MM, Homberg JR. de Veen BT, et al. Expert Rev Neurother. 2017 Feb;17(2):203-212. doi: 10.1080/14737175.2016.1220834. Epub 2016 Aug 12. Expert Rev Neurother. 2017. PMID: 27684102 Review.

5

Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring.

Martial LC, Aarnoutse RE, Mulder M, Schellekens A, Brüggemann RJM, Burger DM, Schene AH, Batalla A. Martial LC, et al. Eur Neuropsychopharmacol. 2017 Mar;27(3):205-216. doi: 10.1016/j.euroneuro.2017.01.009. Epub 2017 Jan 24. Eur Neuropsychopharmacol. 2017. PMID: 28130001 Review.

6

Disruption of Reward Processing in Addiction : An Image-Based Meta-analysis of Functional Magnetic Resonance Imaging Studies.

Luijten M, Schellekens AF, Kühn S, Machielse MW, Sescousse G. Luijten M, et al. JAMA Psychiatry. 2017 Apr 1;74(4):387-398. doi: 10.1001/jamapsychiatry.2016.3084. JAMA Psychiatry. 2017. PMID: 28146248

7

Are There Differences in Disruptions of Reward Processing Between Substance Use Disorder and Gambling Disorder?-Reply.

Schellekens AF, Luijten M, Sescousse G. Schellekens AF, et al. JAMA Psychiatry. 2017 Jul 1;74(7):760-761. doi: 10.1001/jamapsychiatry.2017.1054. JAMA Psychiatry. 2017. PMID: 28593251 No abstract available.

8

Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model.

van de Wijer L, Garcia LP, Hanswijk SI, Rando J, Middelman A, Ter Heine R, Mast Q, Martens GJM, van der Ven AJAM, Kolk SM, Schellekens AFA, Homberg JR. van de Wijer L, et al. Among authors: schellekens afa. Transl Psychiatry. 2019 Feb 11;9(1):84. doi: 10.1038/s41398-019-0420-y. Transl Psychiatry. 2019. PMID: 30745561 Free PMC article.

9

Brain responses to anticipating and receiving beer: Comparing light, at-risk, and dependent alcohol users.

Groefsema MM, Engels RCME, Voon V, Schellekens AFA, Luijten M, Sescousse G. Groefsema MM, et al. Among authors: schellekens afa. Addict Biol. 2020 May;25(3):e12766. doi: 10.1111/adb.12766. Epub 2019 May 7. Addict Biol. 2020. PMID: 31066137 Free PMC article.

10

Delayed complications after severe clozapine intoxication: a case report. The pharmacokinetic profile of clozapine and it's important role in the course of symptoms.

van Helvoort M, van Eijndhoven P, Schellekens A, Pop-Purceleanu M, Kramers C, Batalla A. van Helvoort M, et al. Int Clin Psychopharmacol. 2019 Sep;34(5):269-272. doi: 10.1097/YIC.0000000000000272. Int Clin Psychopharmacol. 2019. PMID: 31107832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page